Evidence map›Paper›PMID 40034648›Full record

ArticlebioRxiv : the preprint server for biology2025

Post-mitotic transcriptional activation and 3D regulatory interactions show locus- and differentiation-specific sensitivity to cohesin depletion.

UkJin Lee, Alejandra Laguillo-Diego, Wilfred Wong, Zhangli Ni, Lingling Cheng, Jieru Li, Bobbie Pelham-Webb, Alexandros Pertsinidis, Christina Leslie, Effie Apostolou

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

UkJin LeeSanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.ORCID 0000-0001-6644-4286
Alejandra Laguillo-DiegoSanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.ORCID 0000-0003-2724-789
Wilfred WongComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Zhangli NiStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0009-0002-0813-9835
Lingling ChengStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jieru LiStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Bobbie Pelham-WebbWeill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY 10021, USA.ORCID 0000-0003-0437-8206
Alexandros PertsinidisStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Christina LeslieComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-4571-5910
Effie ApostolouSanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.ORCID 0000-0002-8111-0863

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome FunctionRM1GM139738 · NIGMS · CORNELL UNIVERSITY · PI Thomas George Wade Graham, Steven Zvi Josefowicz · 2021 to 2026
$14.4M
Mechanisms of enhancer-promoter communication, genome organization and transcription controlR01GM144508 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PERTSINIDIS, ALEXANDROS · 2022 to 2025
$1.9M
Organizational principles and functional role of 3D enhancer hubs in cell fate decisionsR01GM138635 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI APOSTOLOU, EFFIE · 2020 to 2023
$1.9M
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM138635NIGMS NIH HHS R01 GM144508NIGMS NIH HHS RM1 GM139738
6 · The paper itself

Abstract

Prior studies showed that structural loops collapse upon acute cohesin depletion, while regulatory enhancer-promoter (E-P) loops largely persist, consistent with minimal transcriptional changes. However, these studies, conducted in asynchronous cells, could not resolve whether cohesin is required for the establishment of regulatory interactions and transcriptional activation during cell division or cell state transitions. To address this gap, we degraded RAD21, a core cohesin subunit, in naïve mouse embryonic stem cells (ESCs) transitioning from mitosis to G1 either in self-renewal condition or during differentiation toward formative pluripotency. Although most structural loops failed to be re-established without cohesin, about 35% of regulatory loops reformed at normal or higher frequencies. Cohesin-independent loops showed characteristics of strong active enhancers and promoters and a significant association with H3K27ac mitotic bookmarks. However, inhibition of CBP/p300 during mitotic exit did not impact these cohesin-independent interactions, suggesting the presence of complex compensatory mechanisms. At the transcriptional level, cohesin depletion induced only minor changes, supporting that post-mitotic transcriptional reactivation is largely independent of cohesin. The few genes with impaired reactivation were directly bound by RAD21 at their promoters, engaged in many structural loops, and located within strongly insulated TADs with low gene density. Importantly, degrading cohesin during the M-to-G1 transition in the presence of EpiLC differentiation signals revealed a larger group of susceptible genes, including key signature genes and transcription factors. Impaired activation of these genes was partly due to the failure to establish

Identifiers

PMID40034648
PMCPMC11875242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.